Evidence map›Paper›PMID 18930603›Full record

Trial reportDrug and alcohol dependence2009

Buprenorphine and methadone maintenance in jail and post-release: a randomized clinical trial.

Stephen Magura, Joshua D Lee, Jason Hershberger, Herman Joseph, Lisa Marsch, Carol Shropshire, Andrew Rosenblum

Open access · greenAbstract readComparative StudyRandomized Controlled Trial
In one paragraph

Trial report in Drug and alcohol dependence, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 107 papers, 12 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
107citing papers in PubMed, 12 pooled it
8.9field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

107 citing papers in PubMed, 12 syntheses or guidelines pooled it, 226 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Routes of non-traditional entry into buprenorphine treatment programs.Substance abuse treatment, prevention, and policy · 2020
    Pooled it
  5. Interventions for female drug-using offenders.The Cochrane database of systematic reviews · 2019
    Pooled it
  6. Pooled it
  7. Pooled it
  8. Pharmacological interventions for drug-using offenders.The Cochrane database of systematic reviews · 2015
    Pooled it
  9. Pooled it
  10. Pooled it
  11. Pooled it
  12. Opioid dependence.BMJ clinical evidence · 2011
    Pooled it
  13. Trial
  14. Trial
  15. Trial
  16. Trial
  17. Trial
  18. Trial
  19. Trial
  20. Trial

47 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 1 country.

Stephen MaguraThe Evaluation Center, Western Michigan University, Kalamazoo, MI 49008, USA. stephen.magura@wmich.edu
Joshua D Lee
Jason Hershberger
Herman Joseph
Lisa Marsch
Carol Shropshire
Andrew Rosenblum
National Development and Research Institutes · USFrontLine Service · USNew York University · USWestern Michigan University · US

Funding

Buprenorphine Maintenance for Opioid Addicted Persons in Jail and Post-ReleaseR21DA020583 · NIDA · NATIONAL DEVELOPMENT AND RESEARCH INSTITUTES, INC. · PI MAGURA, STEPHEN · 2006 to 2007
$376k
NIDA NIH HHS R21 DA020583
6 · The paper itself

Abstract

Buprenorphine has rarely been administered as an opioid agonist maintenance therapy in a correctional setting. This study introduced buprenorphine maintenance in a large urban jail, Rikers Island in New York City. Heroin-dependent men not enrolled in community methadone treatment and sentenced to 10-90 days in jail (N=116) were voluntarily randomly assigned either to buprenorphine or methadone maintenance, the latter being the standard of care for eligible inmates at Rikers. Buprenorphine and methadone maintenance completion rates in jail were equally high, but the buprenorphine group reported for their designated post-release treatment in the community significantly more often than did the methadone group (48% vs. 14%, p<.001). Consistent with this result, prior to release from Rikers, buprenorphine patients stated an intention to continue treatment after release more often than did methadone patients (93% vs. 44%, p<.001). Buprenorphine patients were also less likely than methadone patients to withdraw voluntarily from medication while in jail (3% vs. 16%, p<.05). There were no post-release differences between the buprenorphine and methadone groups in self-reported relapse to illicit opioid use, self-reported re-arrests, self-reported severity of crime or re-incarceration in jail. After initiating opioid agonist treatment in jail, continuing buprenorphine maintenance in the community appears to be more acceptable to offenders than continuing methadone maintenance.

Indexed as

PrisonsAdolescentAdultAgedBuprenorphineDiagnosis, Dual (Psychiatry)FemaleFollow-Up StudiesHIV InfectionsHumansMaleMental DisordersMethadoneMiddle AgedNarcoticsOpioid-Related DisordersBuprenorphineMethadoneNarcotics

Identifiers

PMID18930603
PMCPMC2658719
OpenAlexW2052551617

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.